Carregant...

Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity

Dihydropyrimidine dehydrogenase (DPD) is the initial and rate limiting enzyme of the uracil catabolic pathway, being critically important for inactivation of the commonly prescribed anti-cancer drug 5-fluorouracil (5-FU). DPD impairment leads to increased exposure to 5-FU and, in turn, increased ana...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Offer, Steven M., Fossum, Croix C., Wegner, Natalie J., Stuflesser, Alexander J., Butterfield, Gabriel L., Diasio, Robert B.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012613/
https://ncbi.nlm.nih.gov/pubmed/24648345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-2482
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!